Eur Rev Med Pharmacol Sci 2024; 28 (1): 191-198
DOI: 10.26355/eurrev_202401_34904

Effects of thymoquinone in the lungs of rats against radiation-induced oxidative stress

S. Doğru, S. Taysi, A. Yücel

Pulmonology Department, Faculty of Medicine, Gaziantep University, Gaziantep, Turkey. sibeldogru@gantep.edu.tr


OBJECTIVE: Radiotherapy is an important treatment for a wide variety of malignancies, although many cancer patients who receive radiotherapy suffer from serious side effects during and after their treatment. Thymoquinone (TQ), the main active ingredient of Nigella sativa, has been reported to have various pharmacological properties, such as antioxidant, hepatoprotective, neuroprotective, antidiabetic, anti-inflammatory, nephroprotective, anticarcinogenic in many pharmacological and toxicological studies. In this study, we aimed to investigate whether there is a radioprotective effect of TQ on the lung tissue of rats exposed to ionizing radiation.

MATERIALS AND METHODS: This study was designed as a prospective, placebo-controlled study. A total of 40 Sprague-Dawley rats were divided into four groups to test the radiation-protective effectiveness of TQ administered by intraperitoneal injection. Biochemical parameters were studied to assess the radiation-protective effects of TQ.

RESULTS: Oxidative stress parameters, such as oxidative stress index (OSI), lipid hydroperoxide (LOOH) and total oxidant status (TOS), in lung tissue of the rats treated with TQ, were found to be lower than in received irradiation alone. Anti-oxidative parameters, such as total antioxidant status (TAS) level and paraoxonase (PON) activity, were statistically higher in the TR (IR plus TQ group) group compared with other groups.

CONCLUSIONS: Findings show that TQ clearly protects lung tissue from radiation-induced oxidative stress and can be used as a radioprotective agent.

Free PDF Download

To cite this article

S. Doğru, S. Taysi, A. Yücel
Effects of thymoquinone in the lungs of rats against radiation-induced oxidative stress

Eur Rev Med Pharmacol Sci
Year: 2024
Vol. 28 - N. 1
Pages: 191-198
DOI: 10.26355/eurrev_202401_34904